CTOs on the Move

Bayside Manor

www.baysidemanor.com

 
Bayside Manor is a Keansburg, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Premier Diagnostic Health Services

Premier Diagnostic Health Services Inc. (“Premier”, “PDH” or the “Company”) is a Canadian corporation with its head office in Burnaby, British Columbia. PDH designs, finances, builds and operates free standing diagnostic imaging centres with no outside affiliation in Canada, and joint venture, diagnostic imaging centres in China with local hospitals. PDH specializes in PET/CT and MRI scanning for the detection and evaluation of cancer, heart disease and neurological disorders

ACON Laboratories

ACON Laboratories, Inc. develops and manufactures a broad range of lateral flow rapid diagnostic tests that are very high quality and competitively priced.

Neuralstem

Neuralstem is a dual platform regenerative medicine company. The company`s technology enables the production of regionally specific, physiologically relevant neural stem cells for therapeutic use for the treatment of central nervous system (CNS) diseases and has enabled the discovery of a library of patented small molecule neurogenic compounds to treat psychological and cognitive disorders. Neuralstem`s small molecule drug discovery program screens human neural stem cell lines for compounds that may stimulate neurogenesis in the brain, possibly reversing pathologies associated with certain CNS conditions. The company`s lead compound, NSI-189, has completed FDA Phase Ia and Ib safety trials for the treatment of major depressive disorder (MDD). Neuralstem is expecting to launch a Phase II study for MDD in 2015. Neuralstem`s first stem cell therapy product, NSI-566, a spinal cord-derived neural stem cell line, is in ongoing clinical trials to treat amyotrophic lateral sclerosis (ALS, or Lou Gehrig`s disease), for which it has received orphan status designation by the FDA. Dosing in a phase IIa trial was completed in July, 2014. The next trial is anticipated to commence in 2015. In addition to ALS, the company is conducting an NSI-566 Phase I trial in chronic spinal cord injury, with NSI-566 clinical development also underway to treat ischemic

MedVentive Inc.

MedVentive provides leading-edge technology solutions that enable physician groups, integrated delivery systems, health plans and self-insured employers to effect meaningful and measurable change in the quality and cost of care they deliver to patients.

Paradigm Medical Industries

Paradigm Medical Industries is a Salt Lake City, UT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.